Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Act-Alone: Glucocorticoid use and tapering in rheumatoid arthritis patients treated with tocilizumab
2010-019694-15Phase 4Completed
- Sponsor
- Roche
- Start
- Jul 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoints: Description of glucocorticoid use with tocilizumab and Evaluation of systematic glucocorticoid dose reduction after low disease activity. Started Jul 2010; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-019694-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019694-15.